UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate Coronavirus Disease 2019 (COVID-19): A Real-World Experience

Clinical infectious diseases, 2022-03, Vol.74 (6), p.1063-1069

2022

Volltextzugriff (PDF)

The impact of variants and vaccination on the mortality and resource utilization of hospitalized patients with COVID-19

BMC infectious diseases, 2022-08, Vol.22 (1), p.702-11, Article 702

2022

Volltextzugriff (PDF)

Second victim experiences and moral injury as predictors of hospitalist burnout before and during the COVID-19 pandemic

PloS one, 2022-10, Vol.17 (10), p.e0275494-e0275494

2022

Volltextzugriff (PDF)

Outcomes of hospitalized patients with COVID-19 during the course of the pandemic in a fully integrated health system

PloS one, 2022-02, Vol.17 (2), p.e0263417

2022

Volltextzugriff (PDF)

Second victim experiences and moral injury as predictors of hospitalist burnout before and during the COVID-19 pandemic

PloS one, 2022-10, Vol.17 (10), p.e0275494

2022

Volltextzugriff (PDF)

Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States

Hepatology communications, 2020-06, Vol.4 (6), p.890-903

2020

Volltextzugriff (PDF)

Independent Predictors of Mortality and Resource Utilization in Viral Hepatitis Related Hepatocellular Carcinoma

Annals of hepatology, 2017-07, Vol.16 (4), p.555-564

2017

Volltextzugriff (PDF)

Recent Trends in Inpatient Mortality and Resource Utilization for Patients with Stroke in the United States: 2005-2009

Journal of stroke and cerebrovascular diseases, 2013-05, Vol.22 (4), p.491-499

2013

Volltextzugriff (PDF)

In-Hospital Mortality and Economic Burden Associated With Hepatic Encephalopathy in the United States From 2005 to 2009

Clinical gastroenterology and hepatology, 2012-09, Vol.10 (9), p.1034-1041.e1

2012

Volltextzugriff (PDF)

Trends in Hospitalized Venous Thromboembolic Diseases in the United States

Chest, 2012-10, Vol.142 (4), p.857A-857B

2012

Volltextzugriff (PDF)

Trends in Mortality and Resource Utilization in Patients Requiring Hospitalization for Pneumonia

Chest, 2012-10, Vol.142 (4), p.140A-140B

2012

Volltextzugriff (PDF)

In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not

Metabolism, clinical and experimental, 2013-03, Vol.62 (3), p.352-360

2013

Volltextzugriff (PDF)

Demographics, Resource Utilization, and Outcomes of Elderly Patients With Chronic Liver Disease Receiving Hospice Care in the United States

The American journal of gastroenterology, 2017-11, Vol.112 (11), p.1700-1708

2017

Volltextzugriff (PDF)

Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016

Medicine (Baltimore), 2018-08, Vol.97 (31), p.e11518-e11518

2018

Volltextzugriff (PDF)

The portrait of an adult liver transplant recipient in the United States from 1987 to 2013

JAMA internal medicine, 2014-08, Vol.174 (8), p.1407

2014

Volltextzugriff (PDF)

Trends in outpatient resource utilizations and outcomes for Medicare beneficiaries with nonalcoholic fatty liver disease

Journal of clinical gastroenterology, 2015-03, Vol.49 (3), p.222-227

2015

Volltextzugriff (PDF)

Tu1483 – Prevalence, Mortality and Health Care Utilization of Hepatits C Infection (HCV) Among Medicare Benificiaries Receiving Chronic Hemodialysis (HD)

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-1338-S-1338

2019

Volltextzugriff (PDF)

Outcomes of liver transplantation by insurance types in the United States

The American journal of managed care, 2020-04, Vol.26 (4), p.e121-e126

2020

Volltextzugriff (PDF)

Sa1484 - Resource Utilization and Outcomes of Patients with Chronic Hepatitis B (HBV) in the United States

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-1128-S-1128

2018

Volltextzugriff (PDF)

Nonalcoholic Fatty Liver is Contributing to the Increase in Cases of Liver Disease in US Emergency Departments

Journal of clinical gastroenterology, 2019-01, Vol.53 (1), p.58-64

2019

Volltextzugriff (PDF)

Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience

Clinical infectious diseases, 2021-06

2021

Volltextzugriff (PDF)

Tu1507 - Demographics, Resource Utilization and Outcomes of Patients with Chronic Liver Disease Receiving Hospice Care in the United States

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S1189-S1189

2017

Volltextzugriff (PDF)

Service line care delivery model for COVID-19 patient-centric care

The American journal of managed care, 2022-03, Vol.28 (3), p.e80-e87

2022

Volltextzugriff (PDF)

Clinical outcomes and resource utilisation in Medicare patients with chronic liver disease: a historical cohort study

BMJ open, 2014-05, Vol.4 (5), p.e004318-e004318

2014

Volltextzugriff (PDF)

Resource Utilization and Survival Among Medicare Patients with Advanced Liver Disease

Digestive diseases and sciences, 2015-02, Vol.60 (2), p.320-332

2015

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Full Collection 2018

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate Coronavirus Disease 2019 (COVID-19): A Real-World Experience

The impact of variants and vaccination on the mortality and resource utilization of hospitalized patients with COVID-19

Second victim experiences and moral injury as predictors of hospitalist burnout before and during the COVID-19 pandemic

Outcomes of hospitalized patients with COVID-19 during the course of the pandemic in a fully integrated health system

Second victim experiences and moral injury as predictors of hospitalist burnout before and during the COVID-19 pandemic

Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States

Independent Predictors of Mortality and Resource Utilization in Viral Hepatitis Related Hepatocellular Carcinoma

Recent Trends in Inpatient Mortality and Resource Utilization for Patients with Stroke in the United States: 2005-2009

In-Hospital Mortality and Economic Burden Associated With Hepatic Encephalopathy in the United States From 2005 to 2009

Trends in Hospitalized Venous Thromboembolic Diseases in the United States

Trends in Mortality and Resource Utilization in Patients Requiring Hospitalization for Pneumonia

In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not

Demographics, Resource Utilization, and Outcomes of Elderly Patients With Chronic Liver Disease Receiving Hospice Care in the United States

Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016

The portrait of an adult liver transplant recipient in the United States from 1987 to 2013

Trends in outpatient resource utilizations and outcomes for Medicare beneficiaries with nonalcoholic fatty liver disease

Tu1483 – Prevalence, Mortality and Health Care Utilization of Hepatits C Infection (HCV) Among Medicare Benificiaries Receiving Chronic Hemodialysis (HD)

Outcomes of liver transplantation by insurance types in the United States

Sa1484 - Resource Utilization and Outcomes of Patients with Chronic Hepatitis B (HBV) in the United States

Nonalcoholic Fatty Liver is Contributing to the Increase in Cases of Liver Disease in US Emergency Departments

Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience

Tu1507 - Demographics, Resource Utilization and Outcomes of Patients with Chronic Liver Disease Receiving Hospice Care in the United States

Service line care delivery model for COVID-19 patient-centric care

Clinical outcomes and resource utilisation in Medicare patients with chronic liver disease: a historical cohort study

Resource Utilization and Survival Among Medicare Patients with Advanced Liver Disease

Aktive Filter

Suchergebnisse filtern